TrialInvestigational new drugs2014

A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma.

Ana De Jesus-Acosta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.